Reference standards, including pharmacopoeial reference standards, are widely used for quality assessment of drug substances. Leading global pharmacopoeias contain monographs regulating the requirements for the classification, attestation, and use of reference standards. The drug standardization system in the Russian Federation, which includes drug substances, requires revision for the creation and attestation of national reference standards, including pharmacopoeial ones.
Similar content being viewed by others
References
Federal Law No. 429, On Amendments to FL “On the Circulation of Medicines” (2014).
Federal Law No. 61, On the Circulation of Medicines (2010).
Russian Federation State Pharmacopoeia, XIIth Ed., Part 1, Scientific Center for Expertise of Medical Products, Moscow (2008).
European Pharmacopoeia, 8th Ed., European Directorate for the Quality of Medicines and Healthcare; http://online.edqm.eu/entry.htm
United States Pharmacopoeia, 37th Ed., United States Pharmacopeial Convenction; http://www.uspnf.com/uspnf/login
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 49, No. 11, pp. 54 – 56, November, 2015.
Rights and permissions
About this article
Cite this article
Merkulov, V.A., Sakanyan, E.I., Klimov, V.I. et al. Modern Approaches to the Development of Reference Standards for Quality Assessment of Drug Substances. Pharm Chem J 49, 776–778 (2016). https://doi.org/10.1007/s11094-016-1369-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-016-1369-2